You are here: Industry Insights > COVID-19 Vaccine

News List

EpiVax and EpiVax Therapeutics Advance COVID-19 Vaccine Program, EPV-CoV-19 prnewswire
January 04, 2021
EpiVax and EpiVax Therapeutics provide an update on the advancement of their peptide-based COVID-19 vaccine, EPV-CoV-19.
UK approves AstraZeneca’s Covid-19 vaccine for emergency use pharmaceutical-technology
January 04, 2021
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorisation for emergency supply to AstraZeneca’s Covid-19 vaccine in the country.
CBIC relaxes rules for courier import and export of COVID-19 vaccines expresspharma
January 04, 2021
Also instructs customs authorities to form a task force to enable speedy customs clearance of COVID-19 vaccines.
COVAXIN clinical trials recruit 23,000 subjects expresspharma
January 04, 2021
COVAXIN has been evaluated in approximately 1000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity results.
DCGI approves Covishield and Covaxin for restricted emergency use in India expresspharma
January 04, 2021
DCGI’s decision comes after the Subject Expert Committee of CDSCO met on January 1-2, 2021 and recommended the grant of permission for restricted emergency use of these vaccines.
Pfizer, BioNTech to Supply the EU with 100 mn additional COVID-19 vaccine doses expresspharma
December 31, 2020
Total doses ordered reaches 300 million for 27 EU member states, all 300 million doses expected to be delivered in 2020 and 2021.
UK MHRA approves Oxford/AstraZeneca COVID-19 vaccine expresspharma
December 31, 2020
Britain has ordered 100 million doses of the jab, with 40 million expected to be available by the end of March.
Awaiting India’s approval for COVISHIELD: SII expresspharma
December 31, 2020
The company made this statement after UK's approval of the Oxford-AstraZeneca COVID-19 vaccine.
Recipharm, Moderna sign deal for manufacturing, fill-finish of COVID-19 vaccines expresspharma
December 31, 2020
They have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19 vaccine supply outside of the US.
AstraZeneca and Oxford-made Covid-19 vaccine not ready for EU market approval pharmaceutical-technology
December 30, 2020
The European Medicines Authority (EMA) has said that the drug maker AstraZeneca and the University of Oxford’s COVID-19 vaccine may not be approved in January next year.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page